Myeloperoxidase-derived 2-chlorohexadecanal forms Schiff bases with primary amines of ethanolamine glycerophospholipids and lysine

Chemistry and Physics of Lipids

Volumn 139, Issue 2, 2006, Pages 157-170

  Wildsmith, Kristin R ^a   Albert, Carolyn J ^a   Hsu, Fong Fu ^b   Kao, Jeff L F ^b   Ford, David A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Electrospray ionization mass spectrometry; Endothelial cells; Fatty aldehyde; Phosphatidylethanolamine; Plasmenylcholine; Reactive chlorinating species

Indexed keywords

2 CHLOROHEXADECANAL; ALDEHYDE DERIVATIVE; CYANOBOROHYDRIDE SODIUM; HYDROCHLORIC ACID; LYSINE; MYELOPEROXIDASE; ORGANOBORON DERIVATIVE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; PLASMALOGEN; SCHIFF BASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REDUCTION;

ALDEHYDES; AMINES; CHEMISTRY, PHYSICAL; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; HYDROLYSIS; LYSINE; MOLECULAR STRUCTURE; PEROXIDASE; PHOSPHATIDYLETHANOLAMINES; SCHIFF BASES; TIME FACTORS;

EID: 31844454656     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2005.12.003     Document Type: Article

References (39)

1. C.J. Albert, J.R. Crowley, F.F. Hsu, A.K. Thukkani, and D.A. Ford Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal J. Biol. Chem. 276 2001 23733 23741
2. G.R. Bartlett Phosphorus assay in column chromatography J. Biol. Chem. 234 1959 466 468
3. E.V. Berdyshev, P.C. Schmid, R.J. Krebsbach, C.J. Hillard, C. Huang, N. Chen, Z. Dong, and H.H.O. Schmid Cannabinoid-receptor-independent cell signalling by N-acylethanolamines Biochem. J. 360 2001 67 75
4. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
5. J. Chen, G.I. Henderson, and G.L. Freeman Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart J. Mol. Cell. Cardiol. 33 2001 1919 1927
6. X. Chen, and R.W. Gross Phospholipid subclass-specific alterations in the kinetics of ion transport across biologic membranes Biochemistry 33 1994 13769 13774
7. M.H. Creer, and J. McHowat Selective hydrolysis of plasmalogens in endothelial cells following thrombin stimulation Am. J. Physiol. 275 1998 C1498 C1507
8. A. Daugherty, J.L. Dunn, D.L. Rateri, and J.W. Heinecke Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions J. Clin. Invest. 94 1994 437 444
9. P. Eaton, J.M. Li, D.J. Hearse, and M.J. Shattock Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart Am. J. Physiol. 276 1999 H935 H943
10. D.A. Ford, and R.W. Gross Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation Proc. Natl. Acad. Sci. U.S.A. 86 1989 3479 3483
11. R.W. Gross High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization Biochemistry 23 1984 158 165
12. R.W. Gross Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum Biochemistry 24 1985 1662 1668
13. C.C. Hale, E.G. Ebeling, F.F. Hsu, and D.A. Ford The selective activation of the cardiac sarcolemmal sodium-calcium exchanger by plasmalogenic phosphatidic acid produced by phospholipase D FEBS Lett. 422 1998 247 251
14. J.E. Harrison, and J. Schultz Studies on the chlorinating activity of myeloperoxidase J. Biol. Chem. 251 1976 1371 1374
15. S.L. Hazen, J.P. Gaut, J.R. Crowley, F.F. Hsu, and J.W. Heinecke Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions Biochem. J. 352 2000 693 699
16. S.L. Hazen, F.F. Hsu, D.M. Mueller, J.R. Crowley, and J.W. Heinecke Human neutrophils employ chlorine gas as an oxidant during phagocytosis J. Clin. Invest. 98 1996 1283 1289
17. J.I. Heller, J.R. Crowley, S.L. Hazen, D.M. Salvay, P. Wagner, S. Pennathur, and J.W. Heinecke p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low-density lipoprotein in human atherosclerotic intima J. Biol. Chem. 275 2000 9957 9962
18. P.F. James, and R.A. Zoeller Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome J. Biol. Chem. 272 1997 23532 23539
19. G.A. Jansen, and R.J. Wanders Plasmalogens and oxidative stress: evidence against a major role of plasmalogens in protection against the superoxide anion radical J. Inhib. Met. Dis. 20 1997 85 94
20. S.J. Klebanoff, A.M. Waltersdorph, and H. Rosen Antimicrobial activity of myeloperoxidase Meth. Enzymol. 105 1984 399 403
21. G. Marsche, R. Heller, G. Fauler, A. Kovacevic, A. Nuszkowski, W. Graier, W. Sattler, and E. Malle 2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis Arterio. Thromb. Vasc. Biol. 24 2004 2302 2306
22. O.H. Morand, R.A. Zoeller, and C.R. Raetz Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation J. Biol. Chem. 263 1988 11597 11606
23. J.C. Morris The acid ionization constant of HOCl from 5 to 35 J. Phys. Chem. 70 1966 3798 3805
24. E.A. Podrez, H.M. Abu-Soud, and S.L. Hazen Myeloperoxidase-generated oxidants and atherosclerosis Free Radic. Biol. Med. 28 2000 1717 1725
25. W.B. Rizzo, D.A. Craft, A.L. Dammann, and M.W. Phillips Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle J. Biol. Chem. 262 1987 17412 17419
26. H.H.O. Schmid Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? Chem. Phys. Lipids 108 2000 71 87
27. H.H.O. Schmid, P.C. Schmid, and V. Natarajan N-acylated glycerophospholipids and their derivatives Prog. Lipid Res. 29 1990 1 43
28. S.M. Sepe, and R.A. Clark Oxidant membrane injury by the neutrophil myeloperoxidase system II. Injury by stimulated neutrophils and protection by lipid-soluble antioxidants J. Immunol. 134 1985 1896 1901
29. S. Stadelmann-Ingrand, S. Favreliere, B. Fauconneau, G. Mauco, and C. Tallineau Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes Free Radic. Biol. Med. 31 2001 1263 1271
30. S. Stadelmann-Ingrand, R. Pontcharraud, and B. Fauconneau Evidence for the reactivity of fatty aldehydes released from oxidized plasmalogens with phosphatidylethanolamine to form Schiff base adducts in rat brain homogenates Chem. Phys. Lipids 131 2004 93 105
31. T.G. Tessner, D.G. Greene, and R.L. Wykle Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils J. Biol. Chem. 265 1990 21032 21038
32. A.K. Thukkani, C.J. Albert, K.R. Wildsmith, M.C. Messner, B.D. Martinson, F.F. Hsu, and D.A. Ford Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein J. Biol. Chem. 278 2003 36365 36372
33. A.K. Thukkani, F.F. Hsu, J.R. Crowley, R.B. Wysolmerski, C.J. Albert, and D.A. Ford Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant 2-chlorohexadecanal J. Biol. Chem. 277 2002 3842 3849
34. A.K. Thukkani, B.D. Martinson, C.J. Albert, G.A. Vogler, and D.A. Ford Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury Am. J. Physiol. 288 2005 H2955 H2964
35. A.K. Thukkani, J. McHowat, F.F. Hsu, M.L. Brennan, S.L. Hazen, and D.A. Ford Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 108 2003 3128 3133
36. K. Uchida Role of reactive aldehyde in cardiovascular diseases Free Radic. Biol. Med. 28 2000 1685 1696
37. K. Uchida, S. Toyokuni, K. Nishikawa, S. Kawakishi, H. Oda, H. Hiai, and E.R. Stadtman Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis Biochemistry 33 1994 12487 12494
38. R.A. Zoeller, T.J. Grazia, P. LaCamera, J. Park, D.P. Gaposchkin, and H.W. Farber Increasing plasmalogen levels protects human endothelial cells during hypoxia Am. J. Physiol. 283 2002 H671 H679
39. R.A. Zoeller, O.H. Morand, and C.R. Raetz A possible role for plasmalogens in protecting animal cells against photosensitized killing J. Biol. Chem. 263 1988 11590 11596